AMICUS THERAPEUTICS, INC. Insider Trading for July 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AMICUS THERAPEUTICS, INC. for July 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 20 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 5.96 | 16,025 | 95,509 | 103,975 | |
| Jul 20 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 16.00 | 16,025 | 256,400 | 83,499 | 99.5 K to 83.5 K (-16.10 %) |
| Jul 20 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 16.00 | 16,025 | 256,400 | 99,524 | 83.5 K to 99.5 K (+19.19 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Option Exercise | M | 4.38 | 3,000 | 13,140 | 24,000 | |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Option Exercise | M | 4.16 | 2,500 | 10,400 | 20,000 | |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Option Exercise | M | 5.33 | 9,500 | 50,588 | 0 | |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Sell | S | 15.00 | 3,000 | 45,000 | 27,687 | 30.7 K to 27.7 K (-9.78 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Buy | M | 15.00 | 3,000 | 45,000 | 30,687 | 27.7 K to 30.7 K (+10.84 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Sell | S | 15.00 | 2,500 | 37,500 | 27,687 | 30.2 K to 27.7 K (-8.28 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Buy | M | 15.00 | 2,500 | 37,500 | 30,187 | 27.7 K to 30.2 K (+9.03 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Sell | S | 15.00 | 9,500 | 142,500 | 27,687 | 37.2 K to 27.7 K (-25.55 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Valenzano Ken | SVP, Pharmacology & ... | Buy | M | 15.00 | 9,500 | 142,500 | 37,187 | 27.7 K to 37.2 K (+34.31 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Option Exercise | M | 10.53 | 10,000 | 105,300 | 0 | |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Sell | S | 15.00 | 10,000 | 150,000 | 11,933 | 21.9 K to 11.9 K (-45.59 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Buy | M | 15.00 | 10,000 | 150,000 | 21,933 | 11.9 K to 21.9 K (+83.80 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 4.16 | 142,250 | 591,760 | 0 | |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Option Exercise | M | 4.16 | 7,750 | 32,240 | 142,250 | |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 15.03 | 142,250 | 2,137,676 | 83,499 | 225.7 K to 83.5 K (-63.01 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 15.03 | 142,250 | 2,137,676 | 225,749 | 83.5 K to 225.7 K (+170.36 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Sell | S | 15.01 | 7,750 | 116,315 | 83,499 | 91.2 K to 83.5 K (-8.49 %) |
| Jul 15 2015 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | Chairman & CEO | Buy | M | 15.01 | 7,750 | 116,315 | 91,249 | 83.5 K to 91.2 K (+9.28 %) |
| Jul 09 2015 | FOLD | AMICUS THERAPEUTIC ... | Doshi Dipal | SVP Strategy & Bus ... | Option Exercise | M | 0.00 | 12,500 | 0 | 12,500 | |
| Jul 09 2015 | FOLD | AMICUS THERAPEUTIC ... | Doshi Dipal | SVP Strategy & Bus ... | Sell | S | 13.87 | 6,250 | 86,689 | 1,706 | 8 K to 1.7 K (-78.56 %) |
| Jul 09 2015 | FOLD | AMICUS THERAPEUTIC ... | Doshi Dipal | SVP Strategy & Bus ... | Payment of Exercise | F | 14.10 | 4,544 | 64,070 | 7,956 | 12.5 K to 8 K (-36.35 %) |
| Jul 09 2015 | FOLD | AMICUS THERAPEUTIC ... | Doshi Dipal | SVP Strategy & Bus ... | Buy | M | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Option Exercise | M | 2.52 | 1,690 | 4,259 | 9,822 | |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Option Exercise | M | 3.53 | 910 | 3,212 | 4,379 | |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Sell | S | 13.98 | 2,600 | 36,350 | 8,188 | 10.8 K to 8.2 K (-24.10 %) |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Buy | M | 13.98 | 2,600 | 36,350 | 10,788 | 8.2 K to 10.8 K (+31.75 %) |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Option Exercise | M | 4.38 | 10,000 | 43,800 | 25,000 | |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Sell | S | 13.98 | 10,000 | 139,766 | 3,187 | 13.2 K to 3.2 K (-75.83 %) |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Peist Kenneth | VP, Legal & IP | Buy | M | 13.98 | 10,000 | 139,766 | 13,187 | 3.2 K to 13.2 K (+313.77 %) |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | SVP, Chief Patient ... | Option Exercise | M | 2.45 | 2,812 | 6,889 | 39,376 | |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | SVP, Chief Patient ... | Option Exercise | M | 2.52 | 3,463 | 8,727 | 28,075 | |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | SVP, Chief Patient ... | Option Exercise | M | 3.53 | 4,374 | 15,440 | 26,252 | |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | SVP, Chief Patient ... | Sell | S | 13.97 | 10,649 | 148,818 | 5,693 | 16.3 K to 5.7 K (-65.16 %) |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Gershkowitz Jayne | SVP, Chief Patient ... | Buy | M | 13.97 | 10,649 | 148,818 | 16,342 | 5.7 K to 16.3 K (+187.05 %) |